Clinical trial

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

NCT01735175

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-06-01

PhasePHASE3

Study timeline

Study start (unknown)2012-06-01Date precision: month

Registry last updated2017-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neutropenic Complicationsunresolved

Breast Neoplasmsunresolved

Chemotherapy-induced Neutropeniaunresolved

Chemotherapeutic Toxicityunresolved

Interventions

LA-EP2006DRUG

Neulasta®DRUG

Sponsors & collaborators

Sandozlead sponsor

Sandoz GmbHcollaborator

Mapped research locations

Saint PetersburgRussia2 BucharestRomania2 MoscowRussia1 KharkivUkraine1 Kazan'Russia1 IașiRomania1 VinnytsiaUkraine1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01735175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.